MINAPHARM Pharmaceuticals (EGX:MIPH)
Egypt flag Egypt · Delayed Price · Currency is EGP
234.50
+0.65 (0.28%)
At close: Aug 28, 2025

MINAPHARM Pharmaceuticals Ratios and Metrics

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
2,7631,7962,4081,8221,303987
Upgrade
Market Cap Growth
-25.72%-25.41%32.19%39.82%32.02%-5.49%
Upgrade
Enterprise Value
5,6404,3554,0872,6251,4481,101
Upgrade
Last Close Price
234.50160.66213.62143.60100.7074.31
Upgrade
PE Ratio
15.6714.02-3.092.913.46
Upgrade
PS Ratio
0.440.320.620.500.430.42
Upgrade
PB Ratio
0.600.410.690.600.670.62
Upgrade
P/TBV Ratio
0.710.480.800.700.810.79
Upgrade
P/FCF Ratio
-----3.44
Upgrade
P/OCF Ratio
217.768.1123.533.246.292.26
Upgrade
EV/Sales Ratio
0.900.771.050.730.480.47
Upgrade
EV/EBITDA Ratio
3.823.727.632.421.731.77
Upgrade
EV/EBIT Ratio
4.844.6610.912.721.922.04
Upgrade
EV/FCF Ratio
-6.61----3.84
Upgrade
Debt / Equity Ratio
1.211.241.070.800.640.60
Upgrade
Debt / EBITDA Ratio
3.734.486.672.221.491.54
Upgrade
Debt / FCF Ratio
-----3.34
Upgrade
Asset Turnover
0.540.550.500.660.790.74
Upgrade
Inventory Turnover
3.133.262.792.822.902.73
Upgrade
Quick Ratio
0.790.790.700.870.920.84
Upgrade
Current Ratio
1.211.251.151.461.611.34
Upgrade
Return on Equity (ROE)
4.30%4.06%0.68%25.32%26.86%21.14%
Upgrade
Return on Assets (ROA)
6.22%5.64%3.02%11.05%12.42%10.56%
Upgrade
Return on Capital (ROIC)
7.46%6.80%3.67%13.92%16.41%14.07%
Upgrade
Return on Capital Employed (ROCE)
15.00%12.60%7.20%22.40%28.80%29.10%
Upgrade
Earnings Yield
5.99%8.74%-1.33%33.63%35.79%30.47%
Upgrade
FCF Yield
-30.89%-38.82%-53.66%-32.84%-13.86%29.06%
Upgrade
Dividend Yield
1.07%1.56%0.77%1.95%2.90%3.63%
Upgrade
Payout Ratio
20.67%25.57%-9.43%10.68%29.33%
Upgrade
Buyback Yield / Dilution
--3.57%6.67%--
Upgrade
Total Shareholder Return
1.07%1.56%4.34%8.62%2.90%3.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.